Synthesis, radio-synthesis and in vitro evaluation of terminally fluorinated derivatives of HU-210 and HU-211 as novel candidate PET tracers.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Organic and biomolecular chemistry

• Publication date

  2017-03-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1039/c6ob02796bPMID 28210722
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The use of cannabinoids as anticancer agents.

  2016cited by this paper
• In vivo imaging of the cannabinoid CB1 receptor with positron emission tomography

  2015cited by this paper
• Effects of bioisosteric fluorine in synthetic cannabinoid designer drugs JWH-018, AM-2201, UR-144, XLR-11, PB-22, 5F-PB-22, APICA, and STS-135.

  2015cited by this paper
• Controlled-deactivation cannabinergic ligands.

  2013cited by this paper
• CB1 Receptor Allosteric Modulators Display Both Agonist and Signaling Pathway Specificity

  2013cited by this paper
• Direct pharmacological monitoring of the developmental switch in NMDA receptor subunit composition using TCN 213, a GluN2A-selective, glycine-dependent antagonist

  2012cited by this paper
• Synthesis and biological evaluation of bilobol and adipostatin A

  2011cited by this paper
• Evidence that the plant cannabinoid cannabigerol is a highly potent α2‐adrenoceptor agonist and moderately potent 5HT1A receptor antagonist

  2010cited by this paper
• Emerging strategies for exploiting cannabinoid receptor agonists as medicines

  2009cited by this paper
• Development of radioligands for in vivo imaging of type 1 cannabinoid receptors (CB1) in human brain.

  2008cited by this paper
• C1'-cycloalkyl side chain pharmacophore in tetrahydrocannabinols.

  2007cited by this paper
• Synthesis of phytyl- and chroman-derivatized photoaffinity labels based on alpha-tocopherol.

  2000cited by this paper
• Structural determinants of the partial agonist‐inverse agonist properties of 6′‐azidohex‐2′‐yne‐Δ8‐tetrahydrocannabinol at cannabinoid receptors

  1999cited by this paper
• Pharmacophoric requirements for cannabinoid side chains: multiple bond and C1'-substituted delta 8-tetrahydrocannabinols.

  1998cited by this paper
• Development of HU-211 as a neuroprotectant for ischemic brain damage.

  1995cited by this paper
• HU-211, a non-psychotropic cannabinoid, rescues cortical neurones from excitatory amino acid toxicity in culture.

  1993cited by this paper
• Seizure-like activity and cellular damage in rat hippocampal neurons in cell culture.

  1989cited by this paper
• Nonpsychotropic cannabinoid acts as a functional N-methyl-D-aspartate receptor blocker.

  1989cited by this paper
• Enantiomeric cannabinoids: stereospecificity of psychotropic activity

  1988cited by this paper

• Flipping the GPCR Switch: Structure-Based Development of Selective Cannabinoid Receptor 2 Inverse Agonists

  2024cites this paper
• Positron Emission Tomography Imaging of the Endocannabinoid System: Opportunities and Challenges in Radiotracer Development.

  2020cites this paper
• Palmitic acid ester of tetrahydrocannabinol (THC) and palmitic acid diester of 11-hydroxy-THC - Unsuccessful search for additional THC metabolites in human body fluids and tissues.

  2019cites this paper
• Synthesis of Classical/Nonclassical Hybrid Cannabinoids and Related Compounds

  2019cites this paper
• Sleep and Neurochemical Modulation by Cannabidiolic Acid Methyl Ester in Rats.

  2019cites this paper
• Hot off the press.

  2017cites this paper